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The rat OX44/CD53 protein is the prototypic member of a "novel" family of 
proteins. These proteins are characterized by four highly hydrophobic 
transmembrane domains, two small extracellular domains, one of which is 
extensively N-glycosylated, and both the amino and the carboxy terminus 
intracytoplasmic. The function of these proteins remains elusive and several 
possible functions have been suggested depending on the experimental system 
used, but all of them are somehow implicated in the control of cell proliferation by 
binding to an unknown ligand. In rat, CD53 antigen is detected on several mature 
cell types of the hematopoietic system, including macrophages, monocytes, 
granulocytes, leukocytes, and B and T cells, as well as osteoblasts and 
osteoclasts. In rat macrophages we have found that the CD53 protein also 
stimulates the production of nitric oxide (submitted for publication), which is 
implicated in septic and hemorraghic shocks. Preliminary data based on somatic 
cell hybrids indicated that the human CD53 gene is located on chromosome . To 
confirm these data and to determine precisely the location of human CD53 gene in 
chromosome 1, we have used fluorescence in situ hybridization (FISH). Using a rat 
OX-44 cDNA probe, a human genomic clone, hROX44, containing a 17-kb-long 
insert was isolated and demonstrated to include the complete human OX-44/CD53 
gene. FISH was performed as previously reported. Briefly, peripheral blood 
lymphocytes were obtained from a human male by Lymphoprep gradient 
centrifugation and stimulated with phytohemagglutinin for 72 h Colchicine (0.2 
ttg/ml) was added to the culture and kept for 1 h. The X-hROX44 genomic clone 
was labeled by nick-translation with digoxigenin-11-dUTP. After 1 h of suppression 
hybridizition at 37°C, hybridization was performed in 50% formamide containing 
10% dextran sulfate, 2× SSC, and 50 mMphosphate, pH 7.0, 2 ngl of labeled 
probe, and a 500-fold excess of both Cot1 DNA (fast renaturation fraction of 
human genomic DNA) and sonicated human placental DNA at 37°C overnight. 
Washings and detection with TRITC-conjugated antibodies were performed as 
described. Chromosomes were counterstained with 75 ng/ml of 4',6-diamino-2-
phenylindole in antifade medium. After the fluorescence microscopy, GTG-banding 
was performed as described. A total of 35 metaphase spreads were analyzed for 
the presence of fluorescent spots; 89% of them showed hybridization signals on 
the pericentromeric region of the short arm of chromosome 1, in one (39%) or both 
(61%) chromatids (Fig. 1). Hybridization was highly specific, and no other 
chromosomes showed spots systematically. This nonrandom distribution was 
analyzed after GTGbanding of metaphases spreads to determine the precise 
location of the CD53 gene (Figs. 1A and 1B). The results of this analysis are 
summarized in Fig. 2; 62 and 19% of the hybridization spots were localized on the 
lp13 and lp21 bands, respectively.  
From these data we conclude that the human CD53 gene maps to lp13, proximal 
to lp21. 
 
 
 
 
 
FIG. 1. Fluorescence in situ hybridization on human chromosomes with a digoxigenin-labeled 17-kb-long 
genomic DNA probe of the human CD53 gene. Arrows indicate the specific site of hybridization. (A) 
Rhodamine detection of digoxigenin-labeled probe and DAPI counterstaining 
in human mitotic cells and GTG-banding of the same metaphase spread. (B) Examples of chromosome 1 from 
other cells. 
 
Chromosomal region lp13 contains some other lymphoid genes like CD2 and its 
ligand CD58 (12). Whether the three lymphoid genes are linked, forming a cluster, 
is currently unknown. Interestingly, CD53 and. CD2 antigens coprecipitate with 
antibodies against CD53 in rat T lymphocytes and natural killer cells, suggesting 
that they are associated on the cell membrane (3). Furthermore, in these cells the 
response to antigenic stimulation of CD2 ÷ cells is increased severalfold if they are 
CD53 ÷ (3). These observations raise the possibility that these two genes might 
have a coordinated expression in T-cells. This interaction and the pattern of OX-
44/CD53 expression at different stages of hematopoietic development and in very 
different mature cell types make the regulation of CD53 gene transcription an 
interesting problem. Chromosomal translocations specific for leukemias have 
been very instrumental in the discovery of genes implicated in oncogenesis. There 
are some translocations involving the lp13 region in different types of tumors (7). 
Among them is t(1;22) (p13;q13), which is detected in 70% of the cases of M7 
acute megakaryocytic leukemia in young children and has a fatal prognosis (6). 
Because of the possible effects of CD53 on cell proliferation, it might be implicated 
in the oncogenic phenotype. Two RAS-related genes (10), NRAS and RAPIA, and 
other genes, such as NGFB and TSH, which might have effects on the growth 
properties of a cell, also map to lp13. Which genes are affected by the t(1;22) 
(p13;q13) translocation is not known, but a better characterization of this region 
should help to clarify this point. 
 
 
 
FIG. 2. 
Assignment of the CD53 gene to lp13. The idiogram of human chromosome 1 schematically indicates the 
intrachromosomal 
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